Health Care & Life Sciences » Pharmaceuticals | Dong-A Socio Holdings Co. Ltd.

Dong-A Socio Holdings Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
21,465
6,485
66,615
175,690
32,543
163,890
Depreciation, Depletion & Amortization
22,004
21,559
26,311
27,391
23,130
24,149
Other Funds
200,350
953
808
4,561
5
215,164
Funds from Operations
53,922
36,566
91,520
85,498
59,083
75,423
Changes in Working Capital
25,431
49,468
15,983
62,977
17,742
26,722
Net Operating Cash Flow
28,490
12,903
75,538
22,522
76,825
48,701
Capital Expenditures
110,612
88,210
111,273
64,975
29,399
Sale of Fixed Assets & Businesses
505
327
435
3,157
1,088
Purchase/Sale of Investments
36,278
28,762
27,179
15,780
147
Net Investing Cash Flow
143,841
119,882
110,214
68,440
28,473
Cash Dividends Paid - Total
10,678
4,340
4,482
4,667
6,050
Issuance/Reduction of Debt, Net
136,534
76,490
10,248
11,734
62,149
Net Financing Cash Flow
67,584
69,510
19,793
21,943
37,071
Net Change in Cash
183,028
63,362
14,828
24,056
83,552
Free Cash Flow
81,222
100,001
21,340
42,022
51,838
Net Assets from Acquisitions
-
-
25,901
28
-
Other Sources
4,600
1,583
215
3,209
4,380
Change in Capital Stock
6,910
1,687
14,834
19,437
105,266
Exchange Rate Effect
93
87
55
81
1,870
Other Uses
2,057
4,819
869
25,583
4,396

About Dong-A Socio Holdings Co.

View Profile
Address
64 Cheonho-daero
Seoul SL 02587
Korea, Republic Of
Employees -
Website http://www.donga.co.kr
Updated 07/08/2019
Dong-A Socio Holdings Co., Ltd. engages in the manufacture of pharmaceutical preparations and products. It operates through the following divisions: Holding Company, Pharmaceuticals, Logistics, Packaging, and Others. The Pharmaceuticals division manufactures and sales pharmaceutical products such as prescription medicine and over-the-counter drug.